Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette E Fleckenstein

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
European Journal of Pharmacology|January 24, 2007
Persistence of tolerance to methamphetamine-induced monoamine deficitsJonathan P Danaceau, Cassandra E Deering, Jayme E Day, et al.
European Journal of Pharmacology|November 27, 2002
Inhibitory effect of reserpine on dopamine transporter functionRyan R Metzger, Jeffrey M Brown, Verónica Sandoval, et al.
European Journal of Pharmacology|July 5, 2008
Differential regional effects of methamphetamine on dopamine transportPei-Wen Chu, Kristi S Seferian, Elisabeth Birdsall, et al.
European Journal of Pharmacology|March 28, 2009
Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatmentJarom E Hanson, Elisabeth Birdsall, Kristi S Seferian, et al.
Drug and Alcohol Dependence|June 1, 2012
Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrationsLisa M McFadden, Madison M Hunt, Paula L Vieira-Brock, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2020
3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine TransportersCharlotte P Magee, Christopher L German, Yasmeen H Siripathane, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 20, 2005
Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicityJannine G Truong, Diana G Wilkins, Jakub Baudys, et al.
Synapse (New York, N.Y.)|November 29, 2011
Methamphetamine self-administration acutely decreases monoaminergic transporter functionLisa M McFadden, Kristen A Stout, Paula L Vieira-Brock, et al.
Synapse (New York, N.Y.)|April 14, 2016
Sex differences in neurotensin and substance P following nicotine self-administration in ratsSteven T Pittenger, Natashia Swalve, Shinnyi Chou, et al.
Neuropharmacology|July 12, 2005
Bupropion increases striatal vesicular monoamine transportKristi S Rau, Elisabeth Birdsall, Jarom E Hanson, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
European Journal of Pharmacology|January 24, 2007
Persistence of tolerance to methamphetamine-induced monoamine deficitsJonathan P Danaceau, Cassandra E Deering, Jayme E Day, et al.
European Journal of Pharmacology|November 27, 2002
Inhibitory effect of reserpine on dopamine transporter functionRyan R Metzger, Jeffrey M Brown, Verónica Sandoval, et al.
European Journal of Pharmacology|July 5, 2008
Differential regional effects of methamphetamine on dopamine transportPei-Wen Chu, Kristi S Seferian, Elisabeth Birdsall, et al.
European Journal of Pharmacology|March 28, 2009
Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatmentJarom E Hanson, Elisabeth Birdsall, Kristi S Seferian, et al.
Drug and Alcohol Dependence|June 1, 2012
Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrationsLisa M McFadden, Madison M Hunt, Paula L Vieira-Brock, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2020
3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine TransportersCharlotte P Magee, Christopher L German, Yasmeen H Siripathane, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 20, 2005
Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicityJannine G Truong, Diana G Wilkins, Jakub Baudys, et al.
Synapse (New York, N.Y.)|November 29, 2011
Methamphetamine self-administration acutely decreases monoaminergic transporter functionLisa M McFadden, Kristen A Stout, Paula L Vieira-Brock, et al.
Synapse (New York, N.Y.)|April 14, 2016
Sex differences in neurotensin and substance P following nicotine self-administration in ratsSteven T Pittenger, Natashia Swalve, Shinnyi Chou, et al.
Neuropharmacology|July 12, 2005
Bupropion increases striatal vesicular monoamine transportKristi S Rau, Elisabeth Birdsall, Jarom E Hanson, et al.
Pageof 8